Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How does sharewise work?

1

Sign up for free

Get yourself a free user account

Show more
2

Look for a stock/index

Choose a specific stock or index

Show more
3

Discuss

Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard

Show more
4

Engage

Help us make sharewise better and help us in making it a success

Show more
sharewise ist auf Deutsch und Englisch verfügbar.
sharewise is available in German and English.

Top Buy/Sell (This Month)

Security Price Target price
Microsoft Corp. €425.15 €501.09
Amazon.com Inc. €227.95 €258.70
Applied Materials Inc. €442.60 €496.17
Security Price Target price
Clorox Co. €91.56 €91.19
Western Union Co. €6.47 €7.01
Socket Mobile Inc. €0.99 -

New Top predictions since last week

Many tell you which stocks to buy.

We measure how often they are right!

Portfolios of our members

Space X
Total
€100,293
Cash
€15,579
Performance (%)
0.293%

Pros and Cons of these stocks (New Predictions)

SpaceX

WKN: A42D4F / Symbol: SPACEX / Name: Space Exploration Technologies Corp. / Stock / ? /

Pros
2
Standard Investments for future growth
1
Leading role in innovation
1
Market Leader or Top 3
Cons
1
negative Cash Flow expected
1
Bad rating
1
Risky balance sheet
Space Exploration Techs. Corp.

WKN: A42DG1 / Name: Space Exploration Techs. Corp. / Stock / ? /

Pros
1
Could be very worthwhile Investment >20% year
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!

Tops & Flops S&P 500

Security Price Change(%) (%)
Carnival Paired Ctf €23.45 5.850%
HF Sinclair Corp. €79.98 5.570%
Discovery Communications C €22.42 5.110%
Sandisk Corp. €1,500.0 4.900%
Fox Corp Class A €59.68 4.670%
Security Price Change(%) (%)
Godaddy Inc €82.04 -3.900%
Ares Management L.P €124.40 -3.680%
Alaska Air Group Inc. €39.73 -3.420%
Idexx Laboratories Inc. €476.00 -3.270%
Gartner Inc. €156.60 -3.210%

Courses

Get started on the stock market in these easy steps
This course is directed at beginners who want to get started on the stock market.

Things you will learn:
  •  What is a stock
  •  What is a fund
  •  What is an ETF
  •  How to open a depot
  •  How to manage a depot that will regularly beat managed funds
  •  Why you mostly need patience to succeed on the stock market

sharewise Introduction:
sharewise Introduction
This is a course about the functionalities of sharewise. You will learn about the basics and how to best use the platform.

Predictions

buy
SpaceX

Start price
Target price
Perf. (%)
€123.22
04:35
€500.00
31.05.30
-0.02%
07:41

Could be very worthwhile Investment >20% year
buy
Space Exploration Techs. Corp.

Start price
Target price
Perf. (%)
€14.00
04:34
€100.00
31.01.29
-
14.08.26

Could be very worthwhile Investment >20% year
buy
Uniqure B.V.

Start price
Target price
Perf. (%)
€41.95
04:30
€100.00
31.05.28
-
14.08.26

Could be very worthwhile Investment >20% year
buy
Advanced Micro Devices Inc.

Start price
Target price
Perf. (%)
€447.10
04:29
€600.00
30.07.28
0.00%
07:40

Could be very worthwhile Investment >20% year

Top News

News

Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth BuildsPhoto, wide shot, wide-angle lens,  Bank, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/094456a7-d529-4ef2-b536-c031f2afd618.png
Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth Builds

Key Points

Rani Therapeutics Expands Oral Biologics Push With Obesity, Immunology Pipeline
Rani Therapeutics Expands Oral Biologics Push With Obesity, Immunology Pipeline

Key Points

QuickLogic Targets Defense, Space Growth With Rad-Hard FPGA PushPhoto, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
QuickLogic Targets Defense, Space Growth With Rad-Hard FPGA Push

Key Points

Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood TestPhoto, wide shot, wide-angle lens,  Bank, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/094456a7-d529-4ef2-b536-c031f2afd618.png
Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test

Key Points

Qualys Conference: ETM and Patch Management Drive Growth AmbitionsPhoto, wide shot, wide-angle lens,  Data analytics provider, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/d1295d04-cceb-4f1c-be2b-32ca46621336.png
Qualys Conference: ETM and Patch Management Drive Growth Ambitions

Key Points

The Metals Company’s Big Bet Now Comes Down to a LicensePhoto, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
The Metals Company’s Big Bet Now Comes Down to a License

Key Points

Palvella Therapeutics Eyes 2027 QTORIN Approval as Rare-Disease Pipeline ExpandsPhoto, wide shot, wide-angle lens,  Metal fabrication, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.midjourneyapi.xyz/temp/138548fd-aba2-4b3e-b9ee-93725b372952.png
Palvella Therapeutics Eyes 2027 QTORIN Approval as Rare-Disease Pipeline Expands

Key Points

PTC Therapeutics Targets Fabry Gene Therapy in $111M Bankruptcy Auction DealPhoto, wide shot, wide-angle lens, soft focus,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
PTC Therapeutics Targets Fabry Gene Therapy in $111M Bankruptcy Auction Deal

Key Points

People Inc. Targets MGM Deal, Buybacks as It Seeks Sales of Non-Core AssetsPhoto, wide shot, wide-angle lens, soft focus,  Movie theater, sunset photo at golden hour, photo by Marc Adamus: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-gXhfb5xMEy8zG0qLmxYAOaHt.png?st=2023-05-14T13%3A29%3A06Z&se=2023-05-14T15%3A29%3A06Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T01%3A25%3A03Z&ske=2023-05-15T01%3A25%3A03Z&sks=b&skv=2021-08-06&sig=cyWAC06qXhBJ4kv4K4eQVNNwtdGGK962uEjAh4%2B61ZY%3D
People Inc. Targets MGM Deal, Buybacks as It Seeks Sales of Non-Core Assets

Key Points

Contest

Compete in Catch the Monkey ...

... and win a prize!

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren

Heibel Ticker

sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.

Kostenlos ausprobieren

Leeway

Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.

Kostenlos ausprobieren

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren